Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Pipecuronium bromide [USAN:INN:BAN]
RN: 52212-02-9
UNII: R6ZTY81RE1
InChIKey: TXWBOBJCRVVBJF-YTGGZNJNSA-L

Note

  • A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent ( NEUROMUSCULAR NONDEPOLARIZING AGENTS). It is used as a muscle relaxant during ANESTHESIA and surgical procedures.

Molecular Formulas

  • C35-H62-Br2-N4-O4
  • C35-H62-N4-O4.2Br

Molecular Weight

  • 762.7068
 

Classification Codes

  • Drug / Therapeutic Agent
  • Neuromuscular Blocking Agent
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Pipecurium bromide
  • Pipecuronium bromide [USAN:INN:BAN]

Synonyms

  • 4,4'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1,1-dimethylpiperazinium)dibromide, diacetate (ester)
  • Arduan
  • EINECS 257-740-4
  • Pipecurium bromide
  • Pipecuronio bromuro
  • Pipecuronio bromuro [Spanish]
  • Pipecuronium bromide
  • Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, dibromide
  • RGH 1106
  • RGH-1106
  • UNII-R6ZTY81RE1

Systematic Names

  • 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetoxy)androstane-2,16-diyl)bis(1,1-dimethylpiperazinium) dibromide
  • Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, dibromide
  • Piperazinium, 4,4'-(3,17-dihydroxyandrostan-2,16-diyl)bis(1,1-dimethyl-, dibromide, diacetate

Registry Numbers

CAS Registry Number

  • 52212-02-9

FDA UNII

  • R6ZTY81RE1

Other Registry Numbers

  • 67880-85-7
  • 84307-15-3

Related Registry Number

  • 68399-58-6 (Parent)

System Generated Number

  • 0052212029

Molecular Formulas

Molecular Formulas

  • C35-H62-Br2-N4-O4
  • C35-H62-N4-O4.2Br

Molecular Formula Fragments

  • Br
  • C35-H62-N4-O4
  • COMPONENT

Structure Descriptors

InChI

1S/C35H62N4O4.2BrH/c1-24(40)42-32-21-26-9-10-27-28(35(26,4)23-31(32)37-15-19-39(7,8)20-16-37)11-12-34(3)29(27)22-30(33(34)43-25(2)41)36-13-17-38(5,6)18-14-36;;/h26-33H,9-23H2,1-8H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1

InChIKey

TXWBOBJCRVVBJF-YTGGZNJNSA-L

Smiles

[C@H]12[C@H]3[C@@H]([C@@]4([C@@H](CC3)C[C@@H]([C@H](C4)N3CC[N+](CC3)(C)C)OC(=O)C)C)CC[C@@]1([C@H]([C@H](C2)N1CC[N+](CC1)(C)C)OC(=O)C)C.[Br-].[Br-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intramuscular 55300ng/kg (0.0553mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
mouse LD50 intraperitoneal 70600ng/kg (0.0706mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
mouse LD50 intravenous 29700ng/kg (0.0297mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
mouse LD50 oral 22mg/kg (22mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
mouse LD50 subcutaneous 60500ng/kg (0.0605mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
rabbit LD50 intravenous 10200ng/kg (0.0102mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
rat LD50 intraperitoneal 450ug/kg (0.45mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
rat LD50 intravenous 173ug/kg (0.173mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.
rat LD50 subcutaneous 456ug/kg (0.456mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 346, 1980.